Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Artigo em Inglês | WPRIM (Pacífico Ocidental) | ID: wpr-224916

RESUMO

We present a 50-year-old woman with left adrenal sarcoidosis. She visited our hospital for right upper quadrant discomfort; she was then evaluated for right upper quadrant discomfort. She had no abnormal findings in the laboratory examination, including hormone study, but a mass was detected at left adrenal gland, incidentally. Initially, we thought the mass as nonfunction adrenal adenoma. After she had undergone laparoscopic left adrenalectomy, she was diagnosed with left adrenal sarcoidosis from her histological findings. Adrenal sarcoidosis is a very rare disease. This case provides insight to the experience of left adrenal sarcoidosis.


Assuntos
Feminino , Humanos , Pessoa de Meia-Idade , Adenoma , Glândulas Suprarrenais , Adrenalectomia , Doenças Raras , Sarcoidose
2.
Artigo em Coreano | WPRIM (Pacífico Ocidental) | ID: wpr-78870

RESUMO

PURPOSE: This study compared the response evaluation using the WHO (World Health Organization) criteria for patients with breast cancer with that of the RECIST (Response Evaluation Criteria In Solid Tumor) criteria in order to determine the significance of the RECIST criteria in breast cancer. METHODS: Between 2001 and 2005, 42 patients with measurable lesions radiologically receiving neoadjuvant chemotherapy for a breast carcinoma were enrolled in this study. The results were compared using a kappa test as a concordance measure between the two response criteria. RESULTS: With the WHO criteria, the overall response and progression rate were 35.7% (CR 0, PR 15) and 16.6% (PD 7) respectively. On the other hand, the overall response and progression rate using the RECIST criteria were 38.0% (CR 0, PR 16) and 7% (PD 3) respectively. The kappa value as a concordance measure between two response criteria was 0.718. CONCLUSION: The RECIST criteria are comparable to the WHO criteria in evaluating the response of breast cancer patients who have undergone neoadjuvant chemotherapy. A comparison of these results with other studies of more common tumor types supports the implementation of RECIST as the standard criteria for evaluating the treatment response but also for monitoring progression.


Assuntos
Humanos , Neoplasias da Mama , Mama , Tratamento Farmacológico , Mãos , Organização Mundial da Saúde
3.
Artigo em Coreano | WPRIM (Pacífico Ocidental) | ID: wpr-93703

RESUMO

Retroperitoneal cysts are rare, usually asymptomatic, lesions. Mullerian cyst of the retroperitoneum is one of extremely rare disease entities and is considered to be a subtype of urogenital cysts. We present the case of a 38-year-old woman with retroperitoneal Mullerian cyst which was found during her second cadaveric kidney transplantation operation. The two-fist sized cyst was found in left retroperitoneal pelvic space extended from left common iliac artery to pre-vesical region, which compromised iliac vessels for vascular anastomosis during kidney transplantation. After complete cyst excision, the kidney transplant operation could be performed. Histologically, the cyst was lined with benign Mullerian-type epithelium. We report the pathologic findings in a rare case of benign retroperitoneal cyst of Mullerian type which was incidentally found during kidney transplant surgery.


Assuntos
Adulto , Feminino , Humanos , Cadáver , Epitélio , Artéria Ilíaca , Transplante de Rim , Rim , Doenças Raras
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...